MedTrace Logo

Intravitreal Triamcinolone Acetonide for Diabetic Macular Edema

NCT00476918 · Status: UNKNOWN · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2007-05-22

No results posted yet for this study

Summary

Efficacy duration of triamcinolone acetonide (steroid) for treatment of diabetic macular edema. Furthermore, dosage dependency of triamcinolone acetonide comparing a high dosage versus a low dosage.

Conditions

Interventions

DRUG

Intravitreal injection (triamcinolone acetonide)

Sponsors & Collaborators

  • Heidelberg University

    lead OTHER

Principal Investigators

  • Jost Jonas, PhD MD · Dep of Ophthalmology, University of Mannheim

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-07-31
Completion
2007-12-31

Countries

  • Germany

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00476918 on ClinicalTrials.gov